Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth hormone secretagogue receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | rhodopsin-like orphan GPCR | growth hormone secretagogue receptor | 289 aa | 243 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0027 | 0.0356 | 0.0886 |
Trypanosoma brucei | hexokinase | 0.0088 | 0.4019 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0401 | 0.0998 |
Entamoeba histolytica | hexokinase 1 | 0.0088 | 0.4019 | 1 |
Brugia malayi | Hexokinase family protein | 0.0056 | 0.2043 | 0.5082 |
Schistosoma mansoni | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Echinococcus multilocularis | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Trypanosoma brucei | hexokinase | 0.0088 | 0.4019 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0056 | 0.2043 | 0.5082 |
Toxoplasma gondii | hexokinase | 0.0088 | 0.4019 | 0.5 |
Echinococcus granulosus | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0088 | 0.4019 | 1 |
Echinococcus multilocularis | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Echinococcus granulosus | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0088 | 0.4019 | 1 |
Loa Loa (eye worm) | hexokinase type II | 0.0088 | 0.4019 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0 | 0.5 |
Onchocerca volvulus | 0.0088 | 0.4019 | 1 | |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Echinococcus multilocularis | hexokinase type 2 | 0.0088 | 0.4019 | 0.4019 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0401 | 0.0998 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0 | 0.5 |
Brugia malayi | Hexokinase family protein | 0.0027 | 0.0356 | 0.0886 |
Leishmania major | hexokinase, putative | 0.0088 | 0.4019 | 1 |
Brugia malayi | hexokinase type II | 0.0028 | 0.0401 | 0.0998 |
Echinococcus granulosus | hexokinase type 2 | 0.0088 | 0.4019 | 0.4019 |
Loa Loa (eye worm) | hexokinase | 0.0088 | 0.4019 | 1 |
Echinococcus multilocularis | geminin | 0.0188 | 1 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.0088 | 0.4019 | 0.5 |
Onchocerca volvulus | 0.0088 | 0.4019 | 1 | |
Trypanosoma brucei | hexokinase, putative | 0.0088 | 0.4019 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0088 | 0.4019 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 1 | 1 |
Plasmodium vivax | hexokinase, putative | 0.0088 | 0.4019 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 1 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0088 | 0.4019 | 1 |
Brugia malayi | Hexokinase family protein | 0.0088 | 0.4019 | 1 |
Echinococcus granulosus | hexokinase | 0.0088 | 0.4019 | 0.4019 |
Plasmodium falciparum | hexokinase | 0.0088 | 0.4019 | 0.5 |
Onchocerca volvulus | 0.0088 | 0.4019 | 1 | |
Brugia malayi | hexokinase | 0.0088 | 0.4019 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2333 | 0.5804 |
Leishmania major | hexokinase, putative | 0.0088 | 0.4019 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = -9.7 | Agonist activity at GSHR by FLIPR assay | ChEMBL. | 17942309 |
Intrinsic activity (functional) | = 1.1 | Intrinsic activity at GSHR relative to human ghrelin | ChEMBL. | 17942309 |
Intrinsic activity (functional) | = 1.1 | Intrinsic activity at GSHR relative to human ghrelin | ChEMBL. | 17942309 |
Log EC50 (functional) | = 9.7 | Agonist activity at GSHR by FLIPR assay | ChEMBL. | 17942309 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.